Subscribe Register Login
Monday, May 21, 2018, 2:11 a.m.

This exclusive story is reserved for our subscribers.

Support independent journalism by subscribing to the Arkansas Democrat-Gazette.

Subscribe now to continue reading.

New bid for Allergan not even close, board tells suitor Valeant

Allergan's board has unanimously rejected the latest takeover bid from Valeant Pharmaceuticals, and the Botox maker said the offer isn't even worth talking about.

Click here to login or subscribe below.

BEST DEAL
7-Day
Home Delivery
& Online
Online Only
Get Started Get Started
Breaking News
Commenting
Newspaper Content Online
Smartphone Access
Tablet App (iPad) Access
Home Delivery
Sunday Comics, Ad Inserts, Coupons